Francois Nader, President, CEO and Director at NPS PHARMACEUTICALS INC (NPSP), sold 193,458 shares at $33.07 ($6.4M) on 2013-09-26, disclosed to the SEC on 2013-09-30.
Scheduled sale ($6.4M) by President, CEO and Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.07 | 143,503 | $4.7M | 74.5% |
| 2 | $33.60 | 6,497 | $218K | 3.4% |
| 3 | $32.36 | 43,458 | $1.4M | 22.1% |
| Total | $32.93 avg | 193,458 | $6.4M | 100% |
| Filing → |
| NPSP | SELL | 2013-04-10 | $5.1M | — | Filing → |
| NPSP | BUY | 2011-11-10 | $161K | — | Filing → |
| NPSP | SELL | 2010-04-02 | $65K | — | Filing → |